Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2011

Feb 25, 2011

31802_dirs_2011-02-25_8f972fc1-0197-461a-b47f-c23a3e5d5c8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2011-02-23

Reporting Person: HARRISON DONALD C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-23 Common Stock M 3947 $0.57 Acquired 202688 Direct
2011-02-23 Common Stock M 7368 $0.57 Acquired 210056 Direct
2011-02-23 Common Stock S 11315 $10.3357 Disposed 198741 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-23 Stock Option (right to buy) $0.57 M 3947 Disposed 2011-03-29 Common Stock (3947) Direct
2011-02-23 Stock Option (right to buy) $0.57 M 7368 Disposed 2011-03-29 Common Stock (7368) Direct

Footnotes

F1: Prices range from $10.16 per share to $10.56 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

F2: Dr. Harrison was granted 3,947 stock options on March 29, 2001, exercisable cumulatively at a rate of 50% on March 29, 2001 and 50% on March 29, 2002 (one year from date of grant).

F3: Dr. Harrison was granted 7,368 stock options on March 29, 2001, exercisable cumulatively at a rate of 25% per annum beginning on March 29, 2001 (grant date).